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Hirudin, a thrombin inhibitor of the leech, was expressed in BHK cells; the a,-antitrypsin signal peptide was used to direct secretion into the culture 
medium, The recombinant hirudin so produced inhibited thrombin and was shown by labelling experiments with P5S]sulphate to have been post- 
translationally modified. 
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1. %NTRODUCTZON 
Control of haemostasis is of vital medical and phar- 
maceutical importance; the use of genetic engineering 
techniques to create new molecules useful in this regard 
Monoclonal antibodies (mAbs) directed against different regions of 
recombinant hirudin variant 2 (rHV2) purified on Protein A 
Sepharose were a gift from Dr C. Koch (Statens Serum Institut, 
Copenhagen, Denmark). Polyclonal antiserum (raised in goats) 
against rHV2 with a Lys residue in position 41 (rHV2-Lys47) were 
from Neosysrems (Strasbourg, France). Protein A Sepharose was pur- 
is becoming well established [ 1,2]. Post-translational 
modifisations have been shown to confer advantages on 
recombinant proteins intended for pharmaceutical use. 
In the case of hirudin, a small.protejn isolated from the 
blood leech, Hirudo medicins/is, sulphation at Tyr63 
has been shown to increase the efficacy of thrombin in- 
hibition [I%=61. Thus, systems for the production of 
post-translationally modified hirudin’to investigate the 
biochemistry involved are of maj,or interest. 
The object of the work hesdribed here was the 
establishment of such a system; hirudin was shown to 
be secreted and sulphated by BHK cells, when expressed 
from a recombinant vaccinia virus using the 
al-antitrypsin (arAT) signal peptide. 
~_ - _ . - _ _ 
20 000 x g for 2 h (Beckman SWaO) to remove infectious virus. 
chased from Pharmacia (Uppsaia, Sweden). Streptavidin-peroxidase 
complex was purchased from Amersham (Les Ulis; France) and or- 
thophenylene diamine (OPD) was obtained through Sigma. 
2.1. Methods 
DNA was manipulated according to standard techniques [‘?I. The 
hirudin cDNA used here codes for rHV2-Lys47 [g]. Oligonucleotides 
were synthesized using a solid-phase synthesizer (Applied Biosystems, 
Foster City, CA, USA) and 5’-phosphorylated before use, Muta- 
genesis of DNA was carried out as previously described [8]. 
2.2. Production of recombinant vsccinia virus (VV) 
Generation of thymidine kinase negative recombinant VV and the 
expression of proteins from them were done as previously described 
[9]. For protein purification, supernatants of BHK-21 cells infected 
with VV were UV-irradiated for 25 min prior to centrifupatinn at 
2. IvlATERIALS AND METHODS 2.3. “S-Labelling of rHV2-Lys49 irl VV-infected eel/s Monolayers of 1.5 x lo6 BHK-21 cells were infected with wild-type 
Restriction and DNA mr*di?ying enzymes were from New England 
Biolabs (Beverly, MA, USA) or Promega Biotech (Madison, WI, 
USA). Purified human thrombin was from Sigma (La Verpilliere, 
France), Chromcuzyme TH, a chromogenic substrate for chrombin 
was from Boebringer Mannheim (FRG). 
3s§-labelled Nri2SOJ (spec. act. 0.9-1.5 TBy/mg) and 3sS-labelled 
L-cysteine (spec. act. 22 TBq/nmol) were purchased from Amersham 
(Les Ulis, France). 
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or recombinant VV at a multiplicity of 0.2 pfu/cell for 16 h in G- 
MEM + 10% fetal calf seium. The medium was then replaced with 
1 ml of cysteine frek MEM plus 1% bovine serum albumin sup- 
plemented with 250&i [3sS]cysteine. Incubation was for 8 h at 37OC. 
Labelling with 35S042 - was done similarly, except that monolayers of 
7 X IO6 cells were infected and the medium was replaced with 6 ml of 
§Od* - free MEM plus 1% BSA supplemented wirh SO mCi 35S042 - . 
2.4. Immunoprecipitation 
Culture supernatant was harvested and supplemented with the same 
volume of Buffer I (1 M KCI, 2010 Triton X-100,50 mM Tris-MCI, pH 
8.8). 5 pl of an&rHV%Lys47 antiserum per reaction were added and 
incubation performed for 1 h at 20°C. 4 mg of equilibrated Protein 
A Sepharose was then added and incubation continued for 1 h. For 
the competititon assays, an excess of unlabelled rHV2-Lys47 (50 
pg/ml) was added to the superpa+ant xzrior to immunoprecipitation. 
After washing the Scpharong 5 times with Buffer 11 (03 M KC!, 
O.golo Triton X-100, 10 mM Trjs-HCI, pH 8.8) and twice with 10 mM 
Tris-HCI, pH 8.8, 50 &mg Laemmli sample buffer were added, the . 
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samples boiled for 5 min and then examined bypolyacrylamide gel
-K 
O-5 vv WT 
electrophoresis, according toLaemmli [IO], The sample buffer con- 6 ++ VV Hir(alu’, ild) 
lained 10 mM DTT and the electrophoresis buffer 8 M urea, Detec- E m m-e YV ,HlrW) 
tion was by fluorography [l l]* H 75 
z 
2.4. Deterrpination of rHVZ.Lys47 irr cell culture supernatunts by g 50 
ELBA g 
ri-W2-Lys47 in cell supernatants was determined using two mAbs F 25 
recognizing different epitopes of the molecule, one of which was % 
biotinylated. The ELlSA was carried out essentially as described in e---- 
the Amersham handbook supplied with the streptavidin-peroxidase 
100 200 &T+ 
complex, the substrate being o-phenylencdiamine. The absorbance at fi Medium 
492 nm was read in an automated ELIYA reader (Molecular Devices, 
Palo Alto, CA, USA). Supernatants from cells infected with wild- Fig. 2. Detection of anti-thrombin activity in the growth medium of 
type vaccinia virus served as controls. BHK cells infected with recombinant vaccinia viruses bearing the 
cDNA for rHV2-Lys47. VV WT = wild-type vaccinia virus. 
2.4. Assay of mti-protease activity 
Anti-thrombin activity was measured as follows, Aliquots of 
culture medium were mixed with human thrombin in a buffer contain- The second construction is similar; in this case, the 
ing 0,lS M KCI, 0.1% PEG 6000 and 0.1 M Tris-HCI, pH 8.0 in a 1 
ml cuvette. After 20 min at room temperature, residual activity was signal peptide extends to include the first amino acid of 
determined by the addition of 100 nmol of chromozym TH and the mature ulAT molecule. Thus, this construction has 
monitoring the absorbance change at 410 nm over a period of 4 min. a native cleavage site, which will give rise to ‘a 
Uninhibited human thrombin had an activity of 0.04 optical density rHV2-Lys47 molecule containing’an extra Glu residue 
units/min under these conditions. at the N-terminus (I-Iir(Glu’, Ile’), Fig. lb). 
3. RlESeTLTS AND DISCUSSIQN BHK cells were infected with recombinant viruses 
bearing these constructions and the semi-thrombin ac- 
3.1. Expression and secretion of hirudin using the a~ at tivity in the culture medium was measured. The results 
signal sequence are shown in Fig. 2; although rWV2-Lys47 was express- 
To examine whether the processing and modification ed to the same level in both constructions (46 ng/ml as 
of a heterologous protein was possible, two DNA con- determined by ELISA), anti-thrombin activity was only 
structions were made to allow the expression of the detected with the I-Iir(lle’) construction. This indicates 
hirudin variant rHV2-Lys47. This protein is normally that &IV%-Lys47 with an additional Glu residue at the 
sulphated at the Ty? residue [3,12]. As other natural N-terminus has a significantly reduced anti-thrombin 
hirudin variants have been shown to be sulphated at the activity. This can be explained by the 3-dimensional 
C-terminal Tyr residue, rHV2-Lys4i’ can be considered structure of :he thrombin-hirudin complex in. which the 
as being representative of this. protein family. N-terminus of hirudin extends into the active site of 
The constructions used to express rI-IW-Lys47 are thrombin [ 13’; 14]. In addition, the presence of an addi- 
shown diagrammatically in Fig. 1. One construction tional Met residue has been shown to, diminish 
(I-Iir(Ile!), Fig. la) contains the cDNA of rMV2-Lys47 drastically its inhibitory activity [ 151. N-Terminal pro- 
fused directly to the 0rlAT signal peptide; proteolytic tein sequencing of the recombinant hirudin secreted 
from BKH cells will be required to show unequivocally cleavage of the signal peptide must therefore take place 
at an amino acid pair not normally recognised by the the presence of the Glu residue. 
signal peptidase (Ala-Ile instead of Ala-Glu). However, Immunoprecipitation of secreted rHV%-Lys47 aft& 
mature rHV2-Lys47 will be generated upon cleavage. expression in 35S042- containing medium rev&tiled a 7 
kDa protein co-migrating with rNVZL,ys47 labelled in 
the presence of [“S]cysteine (Fig. 3). The effebtive com- 
s Hiruciin cDNA petition of an excess of unlabelled hirudin with the’ 
V.V. HirUle’) 
3sso~2 - labelled protein during immunoprecipitation 
confirmed its ideritity to rHV2-Lys47. Tyr63, in 
rHVSLys47 is located in a reiion with a cluster of 
b negatively charged amino acids (E-E-I-P-E-E-Y-L-Q) in 
V V t-iir(glu’, il3) . the highly accessible C-terminal region of the molecule. 
!3u These features, in addition to a turn inducing amino 
Fig. 1. Schematic representations of constructions used to express the 
acid such as proline near Tyr631 have been proposed to 
rHV2-Lys47 derivatives outlined in the text, Hatched blocks represent be important parts of the recognition sequence for 
the alAT signal peptide and speckled blocks the rHV2-Lys47 cDNA. tyrosine sulphation [ 161, Furthermore, no disulfide, 
The constructions are contained onplasmids carrying viral thymidine bonds have been found between amino acids - 7 to I- 7 
kiiiase scquenccs, enabling recombination with, vaccinia virus. The of a sulphated Tyr residue in other proteins thus making 
amino acids at the join of the : (Y~AT signal peptide and the 
rHV2-Lys47 cDNA are indicated; the arrow indicates the viral 7.5 K sulphation of the other Tyr residue in rHyZLys47 
promoter. (‘rvr3) unlikely [16]. In addition, it was recently shown 
37 
Volume 275, number 1,2 FERS LETTERS November 1990 
1 2 3 4 post-translational modification of other proteins to be 
kDa examined, 
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